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      CLINICAL STUDY ON CEFMETAZOLE SODIUM FOR
TREATING AND PREVENTING URINARY TRACT INFECTION
Seigo HiRAGA， Yasuhiko NAKAME， Hiroki ITQ， Hiroyuki KusuyAMA，
     Junji KuRoKAwA， Hidechika NuMA and Yutaka UcHiJiMA
            From the DePartment of Urology， Saitama Medical School
                       （Director： Prof． M． Komase）
    The in L，itre antibacterial activity of cefmetazole sodiu m on four kinds of clinically isolated bac－
terial species was determined， and the clinical effect of the drug in 20 cases of postoperative or chronic－
complicated urinary tract infection was studied．
    1） The maximum sensitivity distribution rate was under 1．56 yg／ml of MIC either on ．106cells／ml
or 108cells／ml・of inoculum size in 25 strains of E． coli， 25 strains of．Klebsiella Pneumoniae． 25 strains
of Genus Proteus and 20 strains of StaPh］lococcus aureus． This indicates that the antibacterial ag－
tivity of cefmetazole sodium was little influenced by the inoculum size of any of the bacterial spccies．
    2） The patients were 13 males and 7 females with a mean age of56．7 years． The cause of urinary
tract infection was urolegical tumors in 6 cases， urolithiasis in 4 cases， neurogenic bladder in 8 cases，
trauma in 2 cases， inflammation in 2 cases and others in 8 cases． Various operations were p’erformed
on 15 patients， and the other 5 patients were not operated on． Cathete’窒?were inserted into the urethra
or renal pelvis， or ureterocutaneostomy was done in 13 cases； 7 patients did not have catheters inserted．
    3）Two to 4 g of cef net耳zole sodiu皿per day was administered intravenoUsly． The mean duration
of chemotherapy was’9．3 days and mean total dose of administration was 25．5 g．
    4） The clinical effect of the drug was judged good， unchanged or poor chiefly based on the change
of Urinalyses． Depending on these criteria， 4 cases which were determined unchanged， were’finally
judged good as all．of them had had catheters inserted． Overall results we’re gpod in 12 cases and
poor in 8 cases． Effective rate， therefore， was 600／o．
    5） Comparison of the effectiveness of the drug for the patients who had had catheters ihserted
to those whe had not， showed that the administration of cefmetazole sodium was also effective in treat－
ihg chronic urinary tract infection even when catheters were used． A good effect was seen in 6 of
the 7 cas．es （860／o） in which catheters were not used， and in 6 of the 13 cases （460／，） in which catheters
were used．
Key words： Cefmetazole sodium， Antibacterial activity， Clinical effect， Urinary tract infecl’ion．
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                                       （埼玉医科大学：1981年3月～5月）
 耳g・2・a）CMZの菌種別薬剤感受性分布（接種菌量工06／ml）
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  （躯医科大学：1981智月75月）
b）GMZの菌種別薬剤感受性分布．（接種菌量108／ml）
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       われわれもまず当院入院患者からat randomに分離




      菌種別薬剤感受性分布
  1981年3月目ら5月までの3ヵ月間に当大学附属病
 院へ入院した患者から分離されたE・ coli 25株， Kleb－
siella Pneumoniae 25株， Proteus属25株， StaPhyloeoccus
aureus 20株の4菌種を培養しCMZの感受性分布を
測定した．このうち当科より分離されたものは，E．




象  症  例
No． 患者名 年齢・長 原  疾  患  名 カテーテル（腎・尿管・尿道）留置の有無
1 H．S． 74 4
2＊ S． K． 79 9
3＊ K・lo 66 Ei
4＊ K．S． 36 e
5 Y． K． 76 8



























11＊ K．S． 78 S
12 1・Ye 72 ’9




14 H．Y． 46 ♂ 外傷性尿道狭窄・膀胱タンポナーデ
15 K．Y． 70 ♀ 外傷性膀胱破裂・骨盤骨折
十
十
16 H．S． 27 ♂ 左急性副睾丸炎
17 M。K。 53 ♂ 慢性膀胱炎・脊髄瘍 十
18＊ A．S． 89 e
f9 A．T． 30 e
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Proteus vulgaris 十 E．co］i
Klebsiella pneumoniae
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（手術当日または投与開始日）。c輔行例
8 10 12 14 16 18 20 22 24 （日）
投与日数
Fig．4． CMZ投与量と投与日数
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nosa．4株， Proteus 7雄g爾2株，． Proteus o晦碗∫とE・
coliの混合感染1株， Klebsietla PneumoniaeとCitrobac－



































































無  効 s （400／o）
Table 6．．カテーテル留置とCMZ薬効評価
薬  効   尿所見（白血球数）からの判定
     十 ev十H一 一一一 一
目 効
        一 聰關→ 一
臨床効果 カテーテル留置十
不 変 十 一 十































WBC 7900／mm3， RBC 331×104／mm3． Hb 9．5 gtdl，
Ht 30．1％，血液化学；総蛋白9．791dl， BUN llmg／
dl， creatinine O．9 mgldl， GOT 45 mU／ml， GPT 51
mU／ml， LDH 213mU／ml， Al－P 95 mU！ml，総ビ
リルビン 0．2mg／dl，総コレステロール 122 mg／dl，
Na 141 mEq／l， K 4．6 mEq／l， Cl 100 mEq／1， Ca 8．4
mg／dl， P 3．9 mg／dl，検尿；蛋白（十），糖（一）， pH



































    右腎陰影と第4腰右椎弓根部に






colistin， cephaloridine， gentamicin， ampicillin， car－
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       a）                     b）
    Fig．8． IVP l5分像 a）は術前で右腎の排泄が全く認められない．
        b）は術後で右腎孟・腎杯が描出され，軽度の水腎を示す．
塾
Fig．9． CT像：Xiphoidより17～18cmの画像（下段の右2葉の写真）








Diag 1 L．kidney－normai pattern
  R．kidney－secretion， excretlonとも‘二
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